5-hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein

Journal of Pharmacology and Experimental Therapeutics

Volumn 290, Issue 3, 1999, Pages 1195-1201

  Cohen, Marlene L ^a   Schenck, Kathryn W ^a   Hemrick Luecke, Susan H ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 DIPROPYLAMINO 1,3,4,5 TETRAHYDROBENZ[CD]INDOLE 6 CARBOXAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN 1A RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SAPHENOUS VEIN; SUBCUTANEOUS DRUG ADMINISTRATION; VENOCONSTRICTION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC FIBERS; ANIMALS; ELECTRIC STIMULATION; ERGOLINES; MALE; MUSCLE CONTRACTION; NOREPINEPHRINE; OXADIAZOLES; PIPERAZINES; PYRIDINES; RABBITS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SAPHENOUS VEIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SUMATRIPTAN; SYNAPTIC TRANSMISSION;

EID: 0032774209     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Alabaster VA, Keir RF and Peters CJ (1985) Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 330:33-36.
2. Barrús MT, Marín J and Balfagón G (1993) Presynaptic 5-hydroxytryptamine receptors modulating noradrenaline release in bovine cerebral arteries. J Auton Pharmacol 13:413-423.
3. 1D-like receptors, and a comparison with grafted veins. Naunyn-Schmiedeberg's Arch Pharmacol 345:500-508.
4. ID receptor agonist MK-462. Cephalalgia 15:203.
5. 1Dβ-like autoreceptors in the guinea-pig brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 353:281-289.
6. Chen N-H and Reita MEA (1994) Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino) tetralin. J Neurochem 64:1585-1597.
7. Cohen ML Johnson KW, Schenck KW and Phebus LA (1997) Relationship between serotonergic contractile receptors in canine, and rabbit saphenous veins to human cerebral, and coronary arteries. Cephalalgia 17:631-638.
8. Cohen RA (1985) Serotonergic prejunctional inhibition of canine coronary adrenergic nerves. J Pharmacol Exp Ther 235:76-80.
9. De Mey JG and Vanhoutte PM (1978) Disposition of adrenergic neurotransmitter in saphenous veins of dog and rabbit. Brit J Pharmacol 63:341P-342P.
10. 1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex. Br J Pharmacol 118:681-689.
11. 1A agonist. J Pharmacol Exp Ther 267:58-71.
12. Fuller RW and Perry KW (1989) Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites. J Pharmacol Exp Ther 248:50-56.
13. Gaw AJ, Wadsworth RM and Humphrey PPA (1990) Neurotransmission in the sheep middle cerebral artery: Modulation of responses by 5-HT and haemolysate. J Cereb Blood Flow Metabol 10:409-416.
14. Glusa E and Müller-Schweinitzer (1993) Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins. Naunyn-Schmiedeberg's Arch Pharmacol 347:133-136.
15. Göthert M, Fink K, Molderings G and Schlicker E (1990) 5-Hydroxytryptamine and related drugs and transmitter release from autonomic nerves in the cardiovascular system, in Cardiovascular Pharmacology of 5-Hydroxytryptamine: Prospective Therapeutic Applications (Saxena PR, Wallis DI, Wouters W and Bevan JA eds) pp 285-294, Dordrecht, Kluwer, the Netherlands.
16. Göthert M, Killecker P, Rohn N and Zerkowski H-R (1986) Inhibitory presynaptic 5-hydroxytryptamine (5-HT) receptors on the sympathetic nerves of the human saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 332:317-323.
17. Göthert M, Molderings GJ, Fink K and Schlicker E (1991) Heterogeneity of presynaptic serotonin receptors on sympathetic neurones in blood vessels. Blood Vessels 28:11-18.
18. Humphrey PPA (1978) The effects of α-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein. Br J Pharmacol 63:671-675.
19. 1A receptor enhances acetylcholine release in conscious rats. J Neurochem 62:1804-1808.
20. 1A receptor antagonist, to rat brain. J Neurochem 64:2716-2726.
21. Lewis DI and Coote JH (1990) The influence of 5-hydroxytryptamine agonists and antagonists on identified sympathetic preganglionic neurones in the rat, in vivo. Br J Pharmacol 99:667-672.
22. Levitt B and Hieble JP (1986) Prejunctional α2-adrenoceptors modulate stimulation-evoked norepinephrine release in rabbit lateral saphenous vein. Eur J Pharmacol 132:197-205.
23. Marin J, Salaices M, Gomez B and Lluch S (1981) Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries. J Pharm Pharmacol 33:715-719.
24. 2- and 5-hydroxytryptamine receptors. Fed Proc 37:195-198.
25. 1D subtype. Naunyn-Schmiedeberg's Arch Pharmacol 342:371-377.
26. Müller-Schweinitzer E (1981) Agonist potencies of tryptamine derivatives at pre-and postjunctional receptors in canine saphenous vein. Postgrad Med J 57 (Suppl):36-44.
27. Norevall LI, Matsson L and Forsgren S (1996) 5-Hydroxytryptamine immunoreactivity is detectable in fibres in rat oral tissues. Histochem J 28:485-493.
28. 1D receptor sites. Eur J Pharmacol 300:137-139.
29. 1D receptors. J Med Chem 9:737-763.
30. 1D receptor antagonist. Behav Brain Res 73:157-161.
31. 2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J Neurosci 16:7566-7573.
32. 1-like receptor mediating contraction in the canine coronary artery. Eur J Pharmacol 900:109-112.
33. 3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog. J Pharmacol Exp Ther 226:579-588.